HK1098380A1 - Use of a ginkgo complexes for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive functions and the alleviation of mental fatigue - Google Patents
Use of a ginkgo complexes for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive functions and the alleviation of mental fatigueInfo
- Publication number
- HK1098380A1 HK1098380A1 HK07104973.6A HK07104973A HK1098380A1 HK 1098380 A1 HK1098380 A1 HK 1098380A1 HK 07104973 A HK07104973 A HK 07104973A HK 1098380 A1 HK1098380 A1 HK 1098380A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- medicament
- enhancement
- mental fatigue
- manufacture
- ginkgo
- Prior art date
Links
- 230000003920 cognitive function Effects 0.000 title abstract 4
- 241000218628 Ginkgo Species 0.000 title abstract 3
- 235000011201 Ginkgo Nutrition 0.000 title abstract 3
- 235000008100 Ginkgo biloba Nutrition 0.000 title abstract 3
- 208000019914 Mental Fatigue Diseases 0.000 title abstract 3
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04001937A EP1559430B1 (en) | 2004-01-29 | 2004-01-29 | Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue |
| PCT/EP2005/000738 WO2005074956A1 (en) | 2004-01-29 | 2005-01-26 | Use of a ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1098380A1 true HK1098380A1 (en) | 2007-07-20 |
Family
ID=34639409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK07104973.6A HK1098380A1 (en) | 2004-01-29 | 2007-05-10 | Use of a ginkgo complexes for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive functions and the alleviation of mental fatigue |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8591965B2 (xx) |
| EP (1) | EP1559430B1 (xx) |
| JP (1) | JP5300196B2 (xx) |
| KR (2) | KR101249667B1 (xx) |
| CN (1) | CN1913907B (xx) |
| AT (1) | ATE428312T1 (xx) |
| AU (1) | AU2005210091B2 (xx) |
| CA (1) | CA2554760C (xx) |
| DE (1) | DE602004020574D1 (xx) |
| DK (1) | DK1559430T3 (xx) |
| ES (1) | ES2323864T3 (xx) |
| HK (1) | HK1098380A1 (xx) |
| IL (1) | IL177118A (xx) |
| NO (1) | NO331190B1 (xx) |
| PL (1) | PL219337B1 (xx) |
| PT (1) | PT1559430E (xx) |
| RU (1) | RU2368385C2 (xx) |
| SG (1) | SG172727A1 (xx) |
| SI (1) | SI1559430T1 (xx) |
| WO (1) | WO2005074956A1 (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100723609B1 (ko) * | 2006-04-28 | 2007-06-04 | 주식회사 유유 | 신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법 |
| ES2709633T3 (es) * | 2007-12-21 | 2019-04-17 | Dr Willmar Schwabe Gmbh & Co Kg | Uso de un extracto de hojas de Ginkgo biloba |
| ITTO20080532A1 (it) * | 2008-07-10 | 2010-01-11 | Euro Pharma S R L | Integratore dietetico atto al potenziamento neuronale e sensoriale |
| IT1397386B1 (it) * | 2010-01-12 | 2013-01-10 | Indena Spa | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| CN103156022B (zh) * | 2011-12-09 | 2014-12-17 | 四川科伦药物研究有限公司 | 一种银杏叶保健茶及其制备方法 |
| SG11201703944XA (en) * | 2014-11-20 | 2017-06-29 | Enzymotec Ltd | Phospholipid preparations for the improvement of communication skills |
| JP6923940B2 (ja) | 2016-04-15 | 2021-08-25 | 慶裕 広川 | 認知機能改善剤 |
| CN105901649A (zh) * | 2016-05-03 | 2016-08-31 | 王胜 | 一种含银杏提取物的植物盐及其制备方法 |
| RU2680809C2 (ru) * | 2016-12-20 | 2019-02-27 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Способ получения наноразмерной фитосомальной системы |
| US20200226948A1 (en) * | 2019-01-14 | 2020-07-16 | Robert Warren | Time and Attention Evaluation System |
| KR20220123272A (ko) * | 2020-01-03 | 2022-09-06 | 바이오서치 에스.에이. | 인지 장애 치료용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2929959A1 (de) * | 1979-07-24 | 1981-02-19 | Hoechst Ag | Thermoplastische kunststoffmasse |
| IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| IT1238684B (it) * | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
| TR200400577T4 (tr) * | 1999-12-17 | 2004-04-21 | Pharmaton S.A. | Kognitif yetenekleri artırmak için ginseng ve ginkgo kombinasyonu. |
| US6733797B1 (en) * | 2000-11-15 | 2004-05-11 | William K. Summers | Neuroceutical for improving memory and cognitive abilities |
| KR20020069539A (ko) * | 2001-02-26 | 2002-09-05 | 주식회사 두산 | 뇌세포 보호용 조성물 |
| WO2003013549A2 (de) * | 2001-08-09 | 2003-02-20 | Degussa Food Ingredients Gmbh | Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern |
| JP2003169632A (ja) * | 2001-12-08 | 2003-06-17 | Sapuri:Kk | 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品 |
| JP2003261456A (ja) * | 2002-03-08 | 2003-09-16 | Howaizu:Kk | 脳の老化予防剤 |
| US6572899B1 (en) * | 2002-07-03 | 2003-06-03 | Vitacost.Com, Inc. | Memory loss treatment formulation |
-
2004
- 2004-01-29 EP EP04001937A patent/EP1559430B1/en not_active Expired - Lifetime
- 2004-01-29 DE DE602004020574T patent/DE602004020574D1/de not_active Expired - Lifetime
- 2004-01-29 SI SI200431142T patent/SI1559430T1/sl unknown
- 2004-01-29 AT AT04001937T patent/ATE428312T1/de active
- 2004-01-29 ES ES04001937T patent/ES2323864T3/es not_active Expired - Lifetime
- 2004-01-29 PT PT04001937T patent/PT1559430E/pt unknown
- 2004-01-29 DK DK04001937T patent/DK1559430T3/da active
-
2005
- 2005-01-26 PL PL380826A patent/PL219337B1/pl unknown
- 2005-01-26 RU RU2006127272/15A patent/RU2368385C2/ru active
- 2005-01-26 CN CN2005800033273A patent/CN1913907B/zh active Active
- 2005-01-26 JP JP2006550086A patent/JP5300196B2/ja active Active
- 2005-01-26 KR KR1020117024637A patent/KR101249667B1/ko active IP Right Grant
- 2005-01-26 CA CA2554760A patent/CA2554760C/en active Active
- 2005-01-26 US US10/587,468 patent/US8591965B2/en active Active
- 2005-01-26 WO PCT/EP2005/000738 patent/WO2005074956A1/en active Application Filing
- 2005-01-26 KR KR1020067015129A patent/KR101249633B1/ko active IP Right Grant
- 2005-01-26 SG SG2011046141A patent/SG172727A1/en unknown
- 2005-01-26 AU AU2005210091A patent/AU2005210091B2/en active Active
-
2006
- 2006-07-27 NO NO20063463A patent/NO331190B1/no unknown
- 2006-07-27 IL IL177118A patent/IL177118A/en active IP Right Grant
-
2007
- 2007-05-10 HK HK07104973.6A patent/HK1098380A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1559430E (pt) | 2009-06-16 |
| ATE428312T1 (de) | 2009-05-15 |
| WO2005074956A1 (en) | 2005-08-18 |
| SI1559430T1 (sl) | 2009-08-31 |
| KR20060130148A (ko) | 2006-12-18 |
| IL177118A (en) | 2011-03-31 |
| RU2368385C2 (ru) | 2009-09-27 |
| ES2323864T3 (es) | 2009-07-27 |
| RU2006127272A (ru) | 2008-02-10 |
| AU2005210091A1 (en) | 2005-08-18 |
| DE602004020574D1 (de) | 2009-05-28 |
| CA2554760A1 (en) | 2005-08-18 |
| US8591965B2 (en) | 2013-11-26 |
| DK1559430T3 (da) | 2009-07-20 |
| JP2007519668A (ja) | 2007-07-19 |
| CN1913907B (zh) | 2011-03-30 |
| EP1559430B1 (en) | 2009-04-15 |
| CA2554760C (en) | 2018-10-09 |
| AU2005210091B2 (en) | 2010-06-03 |
| IL177118A0 (en) | 2008-03-20 |
| JP5300196B2 (ja) | 2013-09-25 |
| KR101249633B1 (ko) | 2013-04-02 |
| PL219337B1 (pl) | 2015-04-30 |
| KR20110123289A (ko) | 2011-11-14 |
| NO331190B1 (no) | 2011-10-31 |
| SG172727A1 (en) | 2011-07-28 |
| PL380826A1 (pl) | 2007-03-19 |
| US20080226757A1 (en) | 2008-09-18 |
| KR101249667B1 (ko) | 2013-04-02 |
| NO20063463L (no) | 2006-07-27 |
| CN1913907A (zh) | 2007-02-14 |
| EP1559430A1 (en) | 2005-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1098380A1 (en) | Use of a ginkgo complexes for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive functions and the alleviation of mental fatigue | |
| HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| ATE495445T1 (de) | Verfahren und zusammensetzungen in verbindung mit morbus alzheimer | |
| BRPI0511063A (pt) | lentes de contato coloridas com padrões de anel lìmbico e de ìris combinados | |
| IL177787A0 (en) | 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | |
| EP1817050A4 (en) | DIAGNOSIS AND TREATMENT OF MORBUS ALZHEIMER | |
| WO2009009393A3 (en) | Chromium complexes for improvement of memory and cognitive function | |
| MXPA05009986A (es) | Tratamiento de la enfermedad de alzheimer. | |
| DE60230961D1 (de) | Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung | |
| WO2004077938A3 (en) | Novel chemical entities and methods for their use in treatment of metabolic disorders | |
| DE60009145D1 (de) | Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen | |
| HK1091657A1 (en) | Use of pyrazolopyridines for the treatment of cognitive deficits | |
| USD562612S1 (en) | Infant carrier cover | |
| MX2010008706A (es) | Derivados de fenil-prenilo, de origen marino y sintetico. para el tratamiento de enfermedades o trastornos cognitivos, neurodegenerativos o neuronales. | |
| Cox et al. | The impact of caregiving for a relative with Alzheimer's disease: A comparison of those caring for persons living alone, spousal caregivers, and co-resident adult children. | |
| Nassif | Investigating creativity with the MMPI-2: A preliminary creativity scale | |
| Mero | Asperger Syndrome With Emotional Disorder—Treatment With Psychoanalytic Psychotherapy | |
| Vanka et al. | Caries prevention: A global strategy | |
| AU2001278344A1 (en) | Use of extracts from ginkgo biloba leaves for inducing dreams | |
| Campbell | Sensing disability in Buddhism | |
| 久保光徳 et al. | Evaluation of Pleasure in Riding on a Car Seat | |
| FI20065414A0 (fi) | Maitopohjaisia elintarvikkeita, jotka sisältävät keskushermoston lipidejä | |
| Rao et al. | Sakshin (witness): A directive principle for psychotherapy. | |
| Saucier et al. | Widening Our Horizons in Infant Mental Health. | |
| Greenbaum | " Interviewing prepubertal children about suicidal ideation and behavior": Comment. |